about
Trefoil factor-3 is not a useful marker of mucosal healing in Crohn's disease treated with anti-TNF-α antibodiesPatients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls.The Role of Fecal Calprotectin in Evaluating Intestinal Involvement of Behçet's DiseaseHigher Levels of Serum Zonulin May Rather Be Associated with Increased Risk of Obesity and Hyperlipidemia, Than with Gastrointestinal Symptoms or Disease Manifestations.Calprotectin in serum and zonulin in serum and feces are elevated after introduction of a diet with lower carbohydrate content and higher fiber, fat and protein contents.Calprotectin as a Biomarker for Melioidosis Disease Progression and Management.The Gut Mucosal Firewall and Functional Medicine.The Use of Fecal Calprotectin in Inflammatory Bowel Disease.Gut inflammation and dysbiosis in human motor neuron disease.Zinc Limitation Induces a Hyper-Adherent Goliath Phenotype in Candida albicans.Fecal Calprotectin: A Comparison of Two Commercial Enzymoimmunoassays and Study of Fecal Extract Stability at Room Temperature.Asymptomatic Intestinal Colonization with Protist Blastocystis Is Strongly Associated with Distinct Microbiome Ecological Patterns.Diagnostic Markers for Nonspecific Inflammatory Bowel Diseases.Identifying the etiology and pathophysiology underlying stunting and environmental enteropathy: study protocol of the AFRIBIOTA project
P2860
Q28468381-4A28ECB4-B8A4-47E7-9AF8-DB9788E930F2Q36202746-F6240156-6E0F-4470-B5F4-B5A05ED9DE77Q37236086-98FCD463-445D-43F5-B9E0-6237DF73C185Q37729192-EAE19654-021B-460D-901C-B1A35A282FA7Q37732016-F775EBB6-83D2-4C88-8CA7-CA5B42D3D5C4Q39295421-041E4016-598B-4856-8118-AD6F202404A4Q41525657-90E5E49D-A88D-4500-AD20-5005C1D0FE3AQ42291741-D58A8920-C532-4A28-84AF-85DB615BCD1DQ42365566-7BD7BCFF-48B0-405E-9A6E-339452241F9EQ46252359-C1F053EB-E298-4FCA-BB27-F6D1C4E2FD4AQ55397418-552F81D0-1628-4121-A985-16BC70270101Q55399389-E83EC740-AA3B-4183-A6FC-5F7C9AAED7FBQ55501346-C2006130-5098-47A9-86E1-2C486C112F45Q57942286-8B703F74-A2FF-4C8A-B30F-BFAE04EC3AB6
P2860
description
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
article scientifique (publié 2016)
@fr
articolo scientifico (pubblicato il 2016)
@it
artigo científico (publicado na 2016)
@pt
artikull shkencor
@sq
artículu científicu espublizáu en 2016
@ast
im Januar 2016 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in Clinical and Experimental Gastroenterology
@en
vedecký článok (publikovaný 2016)
@sk
name
Fecal calprotectin in inflammatory bowel disease
@ast
Fecal calprotectin in inflammatory bowel disease
@en
Fecal calprotectin in inflammatory bowel disease
@nl
type
label
Fecal calprotectin in inflammatory bowel disease
@ast
Fecal calprotectin in inflammatory bowel disease
@en
Fecal calprotectin in inflammatory bowel disease
@nl
prefLabel
Fecal calprotectin in inflammatory bowel disease
@ast
Fecal calprotectin in inflammatory bowel disease
@en
Fecal calprotectin in inflammatory bowel disease
@nl
P2860
P921
P3181
P356
P1476
Fecal calprotectin in inflammatory bowel disease
@en
P2093
Natalie E Walsham
Roy A Sherwood
P2860
P3181
P356
10.2147/CEG.S51902
P407
P577
2016-01-01T00:00:00Z